<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7023814</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">32059696</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">7023814</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">2439</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1186/s12888-020-2439-2</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Inclusion and Exclusion Criteria</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Inclusion and Exclusion Criteria</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>OCD (<italic>n</italic> = 250)</th><th>Unaffected Siblings (<italic>n</italic> = 100)</th><th>Healthy Controls (<italic>n</italic> = 250)</th></tr></thead><tbody><tr><td>Inclusion Criteria</td><td><p>• 18–50 years old</p><p>• Principal diagnosis of OCD</p><p>• YBOCS ≥16</p></td><td><p>• 18–50 years old</p><p>• Has sibling with OCD</p></td><td>• 18–50 years old</td></tr><tr><td rowspan="2">Exclusion Criteria</td><td><p>• Lifetime diagnosis of psychosis, bipolar disorder, anorexia, autism, or Tourette disorder</p><p>• Current chronic tic disorder, substance-use disorder, binge-eating disorder, bulimia, or suicidality</p><p>• Current use of psychotropic medications or CBT for OCD</p></td><td><p>• Current or lifetime psychiatric disorder other than MDD or anxiety disorders</p><p>• Current use of psychotropic medications</p></td><td><p>• Current or lifetime psychiatric disorder other than MDD or anxiety disorders (if not in past year)</p><p>• Current or past use of psychotropic medications</p><p>• First-degree relative with OCD or tic disorder</p></td></tr><tr><td colspan="3"><p> • Major medical or neurological diseases</p><p> • IQ &lt; 80</p><p> • Contraindications to MRI</p></td></tr></tbody></table><table-wrap-foot><p><italic>OCD</italic> Obsessive-compulsive disorder, <italic>YBOCS</italic> Yale-Brown Obsessive-Compulsive Severity Scale, <italic>CBT</italic> Cognitive-behavioral therapy, <italic>IQ</italic> Intelligence quotient, <italic>MRI</italic> Magnetic resonance imaging, <italic>MDD</italic> Major depressive disorder</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Inclusion and Exclusion Criteria</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>OCD (n = 250)</th><th>Unaffected Siblings (n = 100)</th><th>Healthy Controls (n = 250)</th></tr></thead><tbody><tr><td>Inclusion Criteria</td><td>• 18–50 years old• Principal diagnosis of OCD• YBOCS ≥16</td><td>• 18–50 years old• Has sibling with OCD</td><td>• 18–50 years old</td></tr><tr><td rowspan="2">Exclusion Criteria</td><td>• Lifetime diagnosis of psychosis, bipolar disorder, anorexia, autism, or Tourette disorder• Current chronic tic disorder, substance-use disorder, binge-eating disorder, bulimia, or suicidality• Current use of psychotropic medications or CBT for OCD</td><td>• Current or lifetime psychiatric disorder other than MDD or anxiety disorders• Current use of psychotropic medications</td><td>• Current or lifetime psychiatric disorder other than MDD or anxiety disorders (if not in past year)• Current or past use of psychotropic medications• First-degree relative with OCD or tic disorder</td></tr><tr><td colspan="3"> • Major medical or neurological diseases • IQ &lt; 80 • Contraindications to MRI</td></tr></tbody></table></div>OCD Obsessive-compulsive disorder, YBOCS Yale-Brown Obsessive-Compulsive Severity Scale, CBT Cognitive-behavioral therapy, IQ Intelligence quotient, MRI Magnetic resonance imaging, MDD Major depressive disorder</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Clinical Domains and Measures</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>Clinical Domains and Measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Clinical Domains</th><th>Measures</th></tr></thead><tbody><tr><td colspan="2">Obsessive-Compulsive Profiles</td></tr><tr><td> Total Severity</td><td>Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]; Obsessive-Compulsive Inventory-R<sup>a</sup> [<xref ref-type="bibr" rid="CR99">99</xref>]</td></tr><tr><td> Dimension Severity</td><td>Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) [<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr><tr><td> Insight</td><td>Brown Assessment of Beliefs Scale (BABS) [<xref ref-type="bibr" rid="CR101">101</xref>]</td></tr><tr><td> Sensory Phenomena</td><td>University of São Paulo Sensory Phenomena Scale (USP-SPS) [<xref ref-type="bibr" rid="CR102">102</xref>]</td></tr><tr><td> Age of Onset</td><td>Structured Clinical Interview for DSM-5 (SCID) [<xref ref-type="bibr" rid="CR103">103</xref>]; Center for OCD and Related Disorders Age of Onset and Course Form</td></tr><tr><td>Depression</td><td>Hamilton Depression Rating Scale (HAM-D) [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td>Anxiety</td><td>Hamilton Anxiety Rating Scale (HAM-A) [<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td>Other Clinical Profiles</td><td>Autism Spectrum Quotient<sup>a</sup> [<xref ref-type="bibr" rid="CR106">106</xref>]; Center for OCD and Related Disorders Tic Questionnaire; Disgust Propensity and Sensitivity Scale<sup>a</sup> [<xref ref-type="bibr" rid="CR107">107</xref>]; Impulsive-Compulsive Behaviours Checklist<sup>a</sup> [<xref ref-type="bibr" rid="CR108">108</xref>]; Obsessive-Compulsive Personality Disorder Questionnaire</td></tr><tr><td>Functioning</td><td>World Health Organization Disability Assessment Schedule 2.0 (WHODAS) [<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td colspan="2">Environmental</td></tr><tr><td> Socioeconomic Status</td><td>Work and Meaning Inventory (WAMI)<sup>a</sup> [<xref ref-type="bibr" rid="CR110">110</xref>];</td></tr><tr><td> Trauma</td><td>Childhood Trauma Questionnaire<sup>a</sup> [<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td> Religiosity</td><td>Religious Behaviors and Beliefs Questionnaire<sup>a</sup> [<xref ref-type="bibr" rid="CR112">112</xref>];</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Self-report measure; all other measures are administered by a trained clinician</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical Domains and Measures</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Clinical Domains</th><th>Measures</th></tr></thead><tbody><tr><td colspan="2">Obsessive-Compulsive Profiles</td></tr><tr><td> Total Severity</td><td>Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [???, ???]; Obsessive-Compulsive Inventory-Ra [???]</td></tr><tr><td> Dimension Severity</td><td>Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) [???]</td></tr><tr><td> Insight</td><td>Brown Assessment of Beliefs Scale (BABS) [???]</td></tr><tr><td> Sensory Phenomena</td><td>University of São Paulo Sensory Phenomena Scale (USP-SPS) [???]</td></tr><tr><td> Age of Onset</td><td>Structured Clinical Interview for DSM-5 (SCID) [???]; Center for OCD and Related Disorders Age of Onset and Course Form</td></tr><tr><td>Depression</td><td>Hamilton Depression Rating Scale (HAM-D) [???]</td></tr><tr><td>Anxiety</td><td>Hamilton Anxiety Rating Scale (HAM-A) [???]</td></tr><tr><td>Other Clinical Profiles</td><td>Autism Spectrum Quotienta [???]; Center for OCD and Related Disorders Tic Questionnaire; Disgust Propensity and Sensitivity Scalea [???]; Impulsive-Compulsive Behaviours Checklista [???]; Obsessive-Compulsive Personality Disorder Questionnaire</td></tr><tr><td>Functioning</td><td>World Health Organization Disability Assessment Schedule 2.0 (WHODAS) [???]</td></tr><tr><td colspan="2">Environmental</td></tr><tr><td> Socioeconomic Status</td><td>Work and Meaning Inventory (WAMI)a [???];</td></tr><tr><td> Trauma</td><td>Childhood Trauma Questionnairea [???]</td></tr><tr><td> Religiosity</td><td>Religious Behaviors and Beliefs Questionnairea [???];</td></tr></tbody></table></div>aSelf-report measure; all other measures are administered by a trained clinician</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Cognitive Tasks and Domains</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table 3</label><caption><p>Cognitive Tasks and Domains</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Brain Circuit</th><th>Cognitive Domain</th><th>Cognitive Task</th><th>Outcomes</th></tr></thead><tbody><tr><td rowspan="2">Dorsal “cognitive” CSTC<sup>a</sup></td><td>Working Memory</td><td>Visual Spatial N-Back [<xref ref-type="bibr" rid="CR71">71</xref>]</td><td>Percent of correct trials overall and per condition</td></tr><tr><td>Planning</td><td>Tower of London [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]</td><td>Percent of correct trials overall and per task load</td></tr><tr><td>Ventral “cognitive” CSTC<sup>a</sup></td><td>Response Inhibition</td><td>Stop-Signal [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]</td><td>Stop signal reaction time</td></tr><tr><td>Ventral “reward” CSTC</td><td>Reward Processing</td><td>Temporal Discounting [<xref ref-type="bibr" rid="CR118">118</xref>–<xref ref-type="bibr" rid="CR121">121</xref>]</td><td>Discount rate parameter on the intertemporal choice task [and risk aversion parameter on the risk aversion task]</td></tr><tr><td>Frontal-Limbic</td><td>Emotion Regulation / Executive Control</td><td>Emotional Stroop [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]</td><td>Mean reaction time and Stroop effect</td></tr><tr><td>Sensorimotor CSTC</td><td>Motor Learning</td><td>Motor Sequencing [<xref ref-type="bibr" rid="CR123">123</xref>–<xref ref-type="bibr" rid="CR126">126</xref>]</td><td>Learning rate, speed and accuracy, variability in motor performance</td></tr><tr><td>Combination of CSTC</td><td>Reward learning / Decision Making</td><td>Two Stage Reinforcement Learning [<xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR128">128</xref>]</td><td>Proportion of decisions to repeat a rewarded choice vs. an unrewarded choice following either a common or rare transition</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>With the frontoparietal network</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cognitive Tasks and Domains</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Brain Circuit</th><th>Cognitive Domain</th><th>Cognitive Task</th><th>Outcomes</th></tr></thead><tbody><tr><td rowspan="2">Dorsal “cognitive” CSTCa</td><td>Working Memory</td><td>Visual Spatial N-Back [???]</td><td>Percent of correct trials overall and per condition</td></tr><tr><td>Planning</td><td>Tower of London [???, ???]</td><td>Percent of correct trials overall and per task load</td></tr><tr><td>Ventral “cognitive” CSTCa</td><td>Response Inhibition</td><td>Stop-Signal [???, ???, ???]</td><td>Stop signal reaction time</td></tr><tr><td>Ventral “reward” CSTC</td><td>Reward Processing</td><td>Temporal Discounting [???–???]</td><td>Discount rate parameter on the intertemporal choice task [and risk aversion parameter on the risk aversion task]</td></tr><tr><td>Frontal-Limbic</td><td>Emotion Regulation / Executive Control</td><td>Emotional Stroop [???, ???]</td><td>Mean reaction time and Stroop effect</td></tr><tr><td>Sensorimotor CSTC</td><td>Motor Learning</td><td>Motor Sequencing [???–???]</td><td>Learning rate, speed and accuracy, variability in motor performance</td></tr><tr><td>Combination of CSTC</td><td>Reward learning / Decision Making</td><td>Two Stage Reinforcement Learning [???, ???]</td><td>Proportion of decisions to repeat a rewarded choice vs. an unrewarded choice following either a common or rare transition</td></tr></tbody></table></div>aWith the frontoparietal network</transformed-table></extracted-table><extracted-table><table-id>Tab4</table-id><table-label>Table 4</table-label><table-caption>MRI Parameters</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table 4</label><caption><p>MRI Parameters</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">MRI Scanner</td></tr><tr><td> Brazil</td><td>Philips Achieva 3.0 T</td></tr><tr><td> India</td><td>Philips Ingenia 3.0 T CX</td></tr><tr><td> Netherlands</td><td>GE 3.0 T Discovery MR750</td></tr><tr><td> South Africa</td><td>Siemens MAGNETOM Skyra 3.0 T</td></tr><tr><td> U.S.</td><td>GE 3.0 T SIGNA Premier</td></tr><tr><td>Head coil</td><td>32-channel or 48-channel<sup>#</sup></td></tr><tr><td colspan="2">MRI Sequences</td></tr><tr><td> Structural T1</td><td>3D sagittal T1-weighted MP-RAGE according to ADNI-3 protocol (1 × 1 × 1 mm resolution)</td></tr><tr><td> rs-fMRI</td><td>T2*-weighted echo-planar images while subjects are awake and keep their eyes closed (10 min, TR = 2200 ms, TE = 28 ms, 3.3 × 3.3 mm in-plane resolution, 3 mm slices with 0.3 mm gap)</td></tr><tr><td> DWI</td><td>multi-shell single spin echo DWI (80 interleaved volumes: 7 b0, 25 b1000, 24 b2000, 24 b3000, 2.5 × 2.5 × 2.5 mm)</td></tr><tr><td> PSIR</td><td>T1-weighted image with improved SNR and gray-white matter contrast (1 × 1 × 1 mm resolution)</td></tr></tbody></table><table-wrap-foot><p>All sites use a 32-channel head coil, except NYC which uses a 48-channel head coil. <italic>Abbreviations</italic>: <italic>rs-fMRI</italic> Resting-state functional Magnetic Resonance Imaging, <italic>DWI</italic> Diffusion weighted Imaging, <italic>PSIR</italic> Phase sensitive inversion recovery</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">MRI Parameters</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">MRI Scanner</td></tr><tr><td> Brazil</td><td>Philips Achieva 3.0 T</td></tr><tr><td> India</td><td>Philips Ingenia 3.0 T CX</td></tr><tr><td> Netherlands</td><td>GE 3.0 T Discovery MR750</td></tr><tr><td> South Africa</td><td>Siemens MAGNETOM Skyra 3.0 T</td></tr><tr><td> U.S.</td><td>GE 3.0 T SIGNA Premier</td></tr><tr><td>Head coil</td><td>32-channel or 48-channel#</td></tr><tr><td colspan="2">MRI Sequences</td></tr><tr><td> Structural T1</td><td>3D sagittal T1-weighted MP-RAGE according to ADNI-3 protocol (1 × 1 × 1 mm resolution)</td></tr><tr><td> rs-fMRI</td><td>T2*-weighted echo-planar images while subjects are awake and keep their eyes closed (10 min, TR = 2200 ms, TE = 28 ms, 3.3 × 3.3 mm in-plane resolution, 3 mm slices with 0.3 mm gap)</td></tr><tr><td> DWI</td><td>multi-shell single spin echo DWI (80 interleaved volumes: 7 b0, 25 b1000, 24 b2000, 24 b3000, 2.5 × 2.5 × 2.5 mm)</td></tr><tr><td> PSIR</td><td>T1-weighted image with improved SNR and gray-white matter contrast (1 × 1 × 1 mm resolution)</td></tr></tbody></table></div>All sites use a 32-channel head coil, except NYC which uses a 48-channel head coil. Abbreviations: rs-fMRI Resting-state functional Magnetic Resonance Imaging, DWI Diffusion weighted Imaging, PSIR Phase sensitive inversion recovery</transformed-table></extracted-table></extracted-tables-set>